...
首页> 外文期刊>Journal of drugs in dermatology: JDD >Efficacy of Isotretinoin and Acitretin in Treatment of Frontal Fibrosing Alopecia: Retrospective Analysis of 54 Cases
【24h】

Efficacy of Isotretinoin and Acitretin in Treatment of Frontal Fibrosing Alopecia: Retrospective Analysis of 54 Cases

机译:异黄素和丙酸素治疗前纤维症的疗效治疗54例的回顾性分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to assess the efficacy of systemic retinoids in treating frontal fibrosing alopecia (FFA). It was based on a retrospective analysis of 54 female patients with FFA treated with: oral isotretinoin at the daily dose of 20 mg (29/54) or acitretin at the daily dose of 20 mg (11/54) or with oral finasteride 5 mg/daily (14/54). The study was conducted between 2007 and 2017 The basic of the study is the measurement of distance between the frontal hairline and the glabellar crease prior to the commencement of treatment and after 6, 12, and 24 months. The treatment with systemic retinoids lasted between 12 and 16 months (the mean duration of treatment was 13.5 months). The primary treatment goal was defined as no further progression of disease after 12 months of treatment, while the secondary treatment goal was defined as no further progression of disease following the discontinuation of systemic retinoids. The primary treatment goal was achieved by 76% (23/29) of patients treated with isotretinoin, 73% (8/11) of patients treated with acitretin, and 43% (6/14) of patients treated with finasteride. The secondary treatment goal was achieved by 72% (21/29) of patients treated with isotretinoin, 73% (8/11) of patients treated with acitretin, and 43% (6/14) of patients treated with finasteride. Thus, the administration of systemic retinoids may be beneficial for the stabilization of frontal hairline in patients with FFA.
机译:本研究旨在评估全身类视黄素醇治疗前纤维化症状(FFA)的疗效。基于对54例FFA患者的回顾性分析:在每日剂量为20毫克(29/54)或每日剂量的每日剂量为20毫克(11/54)或用口服过滤器5毫克的每日剂量(29/54)或丙酸盐/每日(14/54)。该研究在2007年至2017年间进行了该研究的基础是在锻炼开始之前的前毛线和壁板折痕之间的距离和6,12和24个月之间的距离。具有全身类视黄醇的治疗持续12至16个月(平均治疗持续时间为13.5个月)。初级治疗目标定义为治疗12个月后疾病的进一步进展,而次要治疗目标被定义为在停止全身类视黄醇后疾病的进一步进展。初级治疗目标是通过用丙酸丙氨酸治疗的丙氨酸,73%(8/11)患者治疗的76%(23/29)患者实现,43%(6/14)患者用三甾啶处理。二次治疗目标是通过用丙氨酸治疗的丙氨酸治疗的患者的73%(8/11)患者治疗的72%(21/29),43%(6/14)患者治疗过亚匹克。因此,全身类视黄醇的给药可能有利于FFA患者稳定前毛线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号